{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:22:06Z","timestamp":1791181326565,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,2,1]],"date-time":"1993-02-01T00:00:00Z","timestamp":728524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1993,2]]},"DOI":"10.1007\/bf02251279","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T08:43:55Z","timestamp":1132044235000},"page":"257-264","source":"Crossref","is-referenced-by-count":60,"title":["BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties"],"prefix":"10.1007","volume":"110","author":[{"given":"T. P.","family":"Blackburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. S.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Kennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. D.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Piper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Sanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Upton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02251279_CR1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.2042-7158.1987.tb03452.x","volume":"39","author":"BS Alexander","year":"1987","unstructured":"Alexander BS, Wood MD (1987) Stereoselective blockade of central [3H]-5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol. J Pharm Pharmacol 39:664\u2013666","journal-title":"J Pharm Pharmacol"},{"key":"BF02251279_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00169544","volume":"343","author":"GS Baxter","year":"1991","unstructured":"Baxter GS, Craig DA, Clarke DE (1991) 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn-Schmiedeberg's Arch Pharmacol 343:439\u2013446","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02251279_CR3","first-page":"169","volume":"3","author":"DH Bobker","year":"1990","unstructured":"Bobker DH, Williams JT (1990) Ion conductances affected by 5-HT receptor subtypes in mammalian neurons. TINS 3:169\u2013173","journal-title":"TINS"},{"key":"BF02251279_CR4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.1988.tb11542.x","volume":"94","author":"A Bulter","year":"1988","unstructured":"Bulter A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR 38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94:397\u2013412","journal-title":"Br J Pharmacol"},{"key":"BF02251279_CR5","first-page":"212","volume":"30","author":"RSL Chang","year":"1986","unstructured":"Chang RSL, Lotti VJ, Chen TB, Kunkel KA (1986) Characterization of the binding of [3H]-(\u00b1)-L-364, 718: a new, potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. Mol Pharmacol 30:212\u2013217","journal-title":"Mol Pharmacol"},{"key":"BF02251279_CR6","first-page":"803","volume":"35","author":"RSL Chang","year":"1989","unstructured":"Chang RSL, Chen TB, Bock MG, Friedinger RM, Chen R, Rosegay A, Lotti VJ, (1989) Characterisation of the binding of [3H]-L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Mol Pharmacol 35:803\u2013808","journal-title":"Mol Pharmacol"},{"key":"BF02251279_CR7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y Cheng","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099\u20133108","journal-title":"Biochem Pharmacol"},{"key":"BF02251279_CR8","unstructured":"Costall B, Domeney AM, Kelly ME, Naylor RJ, Tyers MB (1988a) Effects of the 5-HT3 receptor antagonists GR 38032F, ICS 205\u2013930 and BRL 43694 in tests for anxiolytic activity. Br J Pharmacol 93:195P"},{"key":"BF02251279_CR9","first-page":"41","volume":"2","author":"B Costall","year":"1988","unstructured":"Costall B, Naylor RJ, Tyers MB (1988b) Recent advances in the neuropharmacology of 5-HT3 agonists and antagonists. Rev Neurosci 2:41\u201347","journal-title":"Rev Neurosci"},{"key":"BF02251279_CR10","first-page":"383","volume-title":"Behavioural pharmacology of 5-HT","author":"B Costall","year":"1989","unstructured":"Costall B, Domeney AM, Gerrard PA, Jones BJ, Kelly ME, Oakley NR, Tyers MB (1989) The anxiolytic activities of the 5-HT3 receptor antagonists GR 38032F, ICS 205\u2013930 and BRL 43694. In: Bevan P, Cools AS, Archer T (eds) Behavioural pharmacology of 5-HT. Lawrence Erlbaum, New Jersey, pp 383\u2013387"},{"key":"BF02251279_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00178965","volume":"342","author":"DA Craig","year":"1990","unstructured":"Craig DA, Eglen RM, Walsh LKM, Perkins LA, Whiting RL, Clarke DE (1990) 5-Methoxytryptamine and 2-methyl-5-hydroxytryptamine-induced desensitisation as a dicriminative tool for the 5-HT3 and putative 5-HT4 receptor in the guineapig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 342:9\u201316","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02251279_CR12","unstructured":"Cutler MG, Dixon AK (1989) Effects of 5-HT3 antagonist, ICS 205\u2013930, on behaviour of mice during social encounters. Br J Pharmacol 96:12P"},{"key":"BF02251279_CR13","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1152\/ajpcell.1978.235.3.C97","volume":"235","author":"A DeLean","year":"1978","unstructured":"DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curve. Am J Physiol 235:E97-E102","journal-title":"Am J Physiol"},{"key":"BF02251279_CR14","unstructured":"Fake CS, King FD, Sanger GJ (1987) BRL43694: a potent and novel 5-HT3 receptor antagonist. Br J Pharmacol 91:333P"},{"key":"BF02251279_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0270(80)90012-6","volume":"2","author":"SE File","year":"1980","unstructured":"File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlodiazepoxide-like drugs. J Neurosci Methods 2:219\u2013238","journal-title":"J Neurosci Methods"},{"key":"BF02251279_CR16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00518776","volume":"326","author":"JR Fozard","year":"1984","unstructured":"Fozard JR (1984) MDL-72222 \u2014 a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 326:36\u201344","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02251279_CR17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.143.7.900","volume":"143","author":"WK Goodman","year":"1986","unstructured":"Goodman WK, Charney DS, Price LH, Woods SW, Heninger GR (1986) Ineffectiveness of clonidine in the treatment of benzodiazepines withdrawal syndrome: report of three cases. Am J Psychiatry 143:900\u2013903","journal-title":"Am J Psychiatry"},{"key":"BF02251279_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","volume":"327","author":"SL Handley","year":"1984","unstructured":"Handley SL, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of fear-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1\u20135","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02251279_CR19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1476-5381.1988.tb11489.x","volume":"93","author":"BJ Jones","year":"1988","unstructured":"Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR 38032F, a 5-HT3 receptor antagonist. Br J Pharmacol 93:985\u2013993","journal-title":"Br J Pharmacol"},{"key":"BF02251279_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-3223(88)90091-1","volume":"23","author":"RS Kahn","year":"1988","unstructured":"Kahn RS, Van Praag HM, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189\u2013208","journal-title":"Biol Psychiatry"},{"key":"BF02251279_CR21","first-page":"291","volume":"4","author":"GA Kennett","year":"1990","unstructured":"Kennett GA, Blackburn TP (1990) Anxiolytic-like actions of BRL 46470A \u2014 a novel 5-HT3 receptor antagonist. J Psychopharmacol 4:291","journal-title":"J Psychopharmacol"},{"key":"BF02251279_CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0014-2999(89)90252-5","volume":"164","author":"GA Kennett","year":"1989","unstructured":"Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of m-CPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164:445\u2013454","journal-title":"Eur J Pharmacol"},{"key":"BF02251279_CR23","unstructured":"Kennett GA, Grewal SS, Upton T, Blackburn TP (1992) Reversal of diazepam withdrawal anxiety by BRL 46470A, a novel 5-HT3 receptor antagonist. Br J Pharmacol 105:173P"},{"key":"BF02251279_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/ajp.143.11.1480-b","volume":"143","author":"DF Klein","year":"1986","unstructured":"Klein DF, Uhde TW, Post RM (1986) Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. Am J Psychiat 143, 235\u2013236","journal-title":"Am J Psychiat"},{"key":"BF02251279_CR25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/330746a0","volume":"330","author":"GJ Kilpatrick","year":"1987","unstructured":"Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746\u2013748","journal-title":"Nature"},{"key":"BF02251279_CR26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1476-5381.1981.tb08749.x","volume":"73","author":"HW Kosterlitz","year":"1981","unstructured":"Kosterlitz HW, Paterson SF, Robson LE (1981) Characterization of Kappa-subtype of the opiate receptor in the guinea-pig brain. Br J Pharmacol 73:939\u2013949","journal-title":"Br J Pharmacol"},{"key":"BF02251279_CR27","unstructured":"Lattimer N, Rhodes KF, Saville VL (1989) Possible differences in 5-HT3 receptors in the rat and the guinea-pig. Br J Pharmacol 96:270P"},{"key":"BF02251279_CR28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-5793(88)81454-6","volume":"226","author":"D Macallan","year":"1988","unstructured":"Macallan D, Lunt GG, Wonnacott S, Swanson K, Rapoport H, Albuquerque EX (1988) Methyllycaconitine and (+)anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett 226:357\u2013363","journal-title":"FEBS Lett"},{"key":"BF02251279_CR29","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/0006-2952(89)90319-5","volume":"38","author":"DR Nelson","year":"1989","unstructured":"Nelson DR, Thomas DR (1989) [3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes. Biochem Pharmacol 38:1693\u20131695","journal-title":"Biochem Pharmacol"},{"key":"BF02251279_CR30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0014-2999(84)90057-8","volume":"106","author":"A Pazos","year":"1985","unstructured":"Pazos A, Hoyer D, Palacios JM (1985) The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur J Pharmacol 106:539\u2013546","journal-title":"Eur J Pharmacol"},{"key":"BF02251279_CR31","unstructured":"Piper DC, Kenney CA, Jenkins E, Blackburn TP, Hughes HC (1991) The anxiolytic activity of BRL 46470A in the Cynomolgus monkey. Biol Psychiatry 29 [115]:P458S"},{"key":"BF02251279_CR32","unstructured":"Piper D, Upton N, Thomas D, Nicholass J (1988) The effects of the 5-HT3 receptor antagonists BRL 43694 and GR 38032F in animal behavioural models of anxiety. Br J Pharmacol 94:314P"},{"key":"BF02251279_CR33","first-page":"424","volume":"9","author":"BP Richardson","year":"1986","unstructured":"Richardson BP, Engel G (1986) The pharmacology and function of 5-HT3 receptors. TINS 9:424\u2013428","journal-title":"TINS"},{"key":"BF02251279_CR34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/316126a0","volume":"316","author":"BP Richardson","year":"1985","unstructured":"Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126\u2013131","journal-title":"Nature"},{"key":"BF02251279_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(89)90695-X","volume":"159","author":"GJ Sanger","year":"1989","unstructured":"Sanger GJ, Nelson DR (1989) Selective and functional 5-hydroxy-tryptamine-3 receptor antagonism by BRL 43694 (Granisetron). Eur J Pharmacol 159:113\u2013124","journal-title":"Eur J Pharmacol"},{"key":"BF02251279_CR36","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1176\/ajp.143.12.1590","volume":"143","author":"E Schweizer","year":"1986","unstructured":"Schweizer E, Rickels K (1986) Failure of buspirone to manage benzodiazepine withdrawal. Am J Psychiatry 143:1590\u20131592","journal-title":"Am J Psychiatry"},{"key":"BF02251279_CR37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.2042-7158.1988.tb05253.x","volume":"40","author":"WW Smith","year":"1988","unstructured":"Smith WW, Sancilio LF, Owera-Atepo JB, Naylor RJ, Lambert L (1988) Zacopride, a potent 5-HT3 antagonist. J Pharm Pharmacol 40:301\u2013303","journal-title":"J Pharm Pharmacol"},{"key":"BF02251279_CR38","first-page":"289","volume":"4","author":"DR Thomas","year":"1990","unstructured":"Thomas DR, Nelson DR, Blackburn TP, Wood MD (1990) BRL 46470A: a novel 5-HT3 receptor antagonist. J Psychopharmacol 4:289","journal-title":"J Psychopharmacol"},{"key":"BF02251279_CR39","first-page":"1042","volume":"ii","author":"P Tyrer","year":"1981","unstructured":"Tyrer P, Rutherford D, Huggett T (1981) Benzodiazepine with-drawal symptoms and propranolol. Lancet ii:1042\u20131043","journal-title":"Lancet"},{"key":"BF02251279_CR40","first-page":"479","volume":"340","author":"C Waeber","year":"1989","unstructured":"Waeber C, Schoeffter P, Palacios JM, Hoyer D (1989) 5-HT1D receptors in guinea-pig and pigeon brain. Radioligand binding and biochemical studies. Naunyn-Schmiedeberg's Arch Pharmacol 340:479\u2013485","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251279.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02251279\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02251279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T13:48:40Z","timestamp":1557928120000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02251279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,2]]}},"alternative-id":["BF02251279"],"URL":"https:\/\/doi.org\/10.1007\/bf02251279","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,2]]}}}